A first-in-class inhibitor of homologous recombination DNA repair counteracts tumour growth, metastasis and therapeutic resistance in pancreatic cancer.
- DOI
- 10.1186/s13046-025-03389-5
- Published
- 2025 Apr 24
- Container
- Journal of experimental & clinical cancer research : CR
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1186/s13046-025-03389-5,
title = {A first-in-class inhibitor of homologous recombination DNA repair counteracts tumour growth, metastasis and therapeutic resistance in pancreatic cancer.},
author = {Calheiros J and Silva R and Barbosa F and Morais J and Moura SR and Almeida S and Fiorini E and Mulhovo S and Aguiar TQ and Wang T and Ricardo S and Almeida MI and Domingues L and Melo SA and Corbo V and Ferreira MU and Saraiva L},
year = {2025},
journal = {Journal of experimental \& clinical cancer research : CR},
doi = {10.1186/s13046-025-03389-5},
url = {https://doi.org/10.1186/s13046-025-03389-5}
}RIS
TY - JOUR TI - A first-in-class inhibitor of homologous recombination DNA repair counteracts tumour growth, metastasis and therapeutic resistance in pancreatic cancer. AU - Calheiros J AU - Silva R AU - Barbosa F AU - Morais J AU - Moura SR AU - Almeida S AU - Fiorini E AU - Mulhovo S AU - Aguiar TQ AU - Wang T AU - Ricardo S AU - Almeida MI AU - Domingues L AU - Melo SA AU - Corbo V AU - Ferreira MU AU - Saraiva L PY - 2025 JO - Journal of experimental & clinical cancer research : CR DO - 10.1186/s13046-025-03389-5 UR - https://doi.org/10.1186/s13046-025-03389-5 ER -
APA
J, C., R, S., F, B., J, M., SR, M., S, A., E, F., S, M., TQ, A., T, W., S, R., MI, A., L, D., SA, M., V, C., MU, F., & L, S. (2025). A first-in-class inhibitor of homologous recombination DNA repair counteracts tumour growth, metastasis and therapeutic resistance in pancreatic cancer.. Journal of experimental & clinical cancer research : CR. https://doi.org/10.1186/s13046-025-03389-5
Source records
- pubmed · retrieved 2026-09-25T11:32:03.035Z